Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Eydenzelt 40 mg/ml solution for injection in a vial {equilateral_black_triangle}

Active Ingredient:
aflibercept
Company:  
Celltrion Healthcare UK Limited See contact details
ATC code: 
S01LA05
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs Audio/Video
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Eydenzelt Patient Guide

Patient guide to explain the use of Eydenzelt with multiple conditions

{pdf_link}

Eydenzelt Prescriber guide

{healthcare_pro_orange} For Healthcare Professionals

Prescriber guide to the use of Eydenzelt

{pdf_link}

Eydenzelt QR code link to patient guide

QR code leaflet to provide QR codes to patient guide

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Celltrion Healthcare UK Limited
Company image
Address
Celltrion Healthcare UK Limited, The Charter Building, Charter Place, Uxbridge, UB8 1JG, UK
WWW
http://www.celltrionhealthcare.co.uk/
Telephone
01753 983 500
Medical Information Direct Line
01753 983 500
Medical Information e-mail
[email protected]
Customer Care direct line
01753 983 500
Adverse event reporting email
[email protected]